Cargando…
Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future
OBJECTIVE: To review the latest progress on the pathogenic mechanism and management of rheumatoid arthritis (RA)-associated coronary artery disease (CAD), and propose advice on future management optimization as well as prospects for research and development of new therapeutic regimen. DATA SOURCES:...
Autores principales: | Wang, Lun, Zhang, Yang, Zhang, Shu-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964948/ https://www.ncbi.nlm.nih.gov/pubmed/31855971 http://dx.doi.org/10.1097/CM9.0000000000000530 |
Ejemplares similares
-
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
por: Romão, Vasco C., et al.
Publicado: (2017) -
Subclinical coronary artery disease in recent-onset of rheumatoid arthritis
por: Jawad, Ali S. M.
Publicado: (2019) -
Genetic Liability to Rheumatoid Arthritis in Relation to Coronary Artery Disease and Stroke Risk
por: Yuan, Shuai, et al.
Publicado: (2022) -
Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017) -
Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis
por: Thomas, Ranjeny
Publicado: (2013)